The ROE as of December 2024 (TTM) for MEI Pharma, Inc. (MEIP) is -110.69%

According to MEI Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -110.69%. This represents a change of 255.87% compared to the average of -31.10% of the last 4 quarters.

MEI Pharma, Inc. (MEIP) Historical ROE (quarterly & annually)

How has MEIP ROE performed in the past?

The mean historical ROE of MEI Pharma, Inc. over the last ten years is -55.35%. The current -110.69% ROE has changed 99.96% with respect to the historical average. Over the past ten years (40 quarters), MEIP's ROE was at its highest in in the September 2023 quarter at 69.28%. The ROE was at its lowest in in the March 2021 quarter at -56.98%.

MEI Pharma, Inc. (MEIP) ROE by Quarter and Year

Discovering the peaks and valleys of MEI Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MEI Pharma, Inc. (MEIP) Average ROE

How has MEIP ROE performed in the past?

The current ROE of MEI Pharma, Inc. (MEIP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MEI Pharma, Inc. (MEIP) ROE vs. Peers

How is MEIP’s ROE compared to its peers?

MEI Pharma, Inc.’s ROE is greater than Magenta Therapeutics, Inc. (-14.27%), greater than Kezar Life Sciences, Inc. (-59.73%), greater than Vincerx Pharma, Inc. (-307.54%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Assembly Biosciences, Inc. (-121.46%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than Instil Bio, Inc. (-37.44%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Achilles Therapeutics plc (-54.57%), greater than Ocular Therapeutix, Inc. (-56.75%), less than Spero Therapeutics, Inc. (3.36%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than HOOKIPA Pharma Inc. (-49.25%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Inozyme Pharma, Inc. (-88.42%), greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Zura Bio Limited (-39.61%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than TransCode Therapeutics, Inc. (-649.01%),

Build a custom stock screener for MEI Pharma, Inc. (MEIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MEI Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MEI Pharma, Inc. (MEIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MEI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.